Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Abbott Laboratories (ABT)

62.37 -0.14 (-0.22%)

05-25 16:00

Open:

62.49

Pre. Close:

62.51

High:

62.58

Low:

62.06

Volume:

3,839,066

Market Cap:

109346M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

62.613 - 62.943

62.943 - 63.224

Low:

61.266 - 61.646

61.646 - 61.969

Close:

61.738 - 62.381

62.381 - 62.927

Technical analysis  (as of: 2018-05-25 4:31:46 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 73.26     One year: 85.56

Support:

Support1: 59.07    Support2: 56.81

Resistance:

Resistance1: 62.72    Resistance2: 73.26

Pivot:

61.04

Moving Averages:

MA(5): 62.04     MA(20): 60.35

MA(100): 60.04     MA(250): 55.25

MACD:

MACD(12,26): 0.76     Signal(12,26,9): 0.53

%K %D:

%K(14,3): 92.17     %D(3): 89.36

RSI:

RSI(14): 60.96

52-Week:

High: 64.6  Low: 44.21  Change(%): 38.6

Average Vol(K):

3-Month: 614312  10-Days 516365

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ABT has closed below upper band by 20.5%. Bollinger Bands are 8.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-23T09:00:00-04:00
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease

2018-05-23T08:06:51-04:00
Abbott's Tendyne mitral valve shows positive effect in global study

2018-05-23T06:00:00-04:00
Abbott's Investigational Tendyne(TM) Device for Mitral Valve Replacement Demonstrates Positive Outcomes at 30 Days in Global Study

2018-05-22T09:25:31-04:00
Abbott's stent guide improved outcomes in long-term study

2018-05-22T06:20:00-04:00
Five-Year Study Data Confirm Positive Outcomes for Patients When Abbott Diagnostic Tool Was Used to Guide Heart Stenting Decisions

2018-05-18T11:44:30-04:00
MeiraGTx Aims For $86 Million U.S. IPO

2018-05-16T12:00:51-04:00
The 30+1 Portfolio: An Average Investor's Reasoning For Buying A Stock

2018-05-03T09:00:00-04:00
Abbott Expands Cardiac Arrhythmias Portfolio with FDA Clearance of Advanced Mapping Catheter

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1753.19

Shares Float (M)

1739.06

% Held by Insiders

% Held by Institutions

74.50

Shares Short (K)

14603

Shares Short Prior Month (K)

12100

Stock Financials

EPS

2.610

EPS Est. Current Year

2.500

EPS Est. Next Year

2.820

EPS Est. Next Quarter

0.560

Forward EPS

3.220

Book Value (p.s.)

3.380

PEG Ratio

1.73

Profit Margin

1.64

Operating Margin

10.73

Return on Assets (ttm)

0.6

Return on Equity (ttm)

1.5

Qtrly Rev. Growth

42.3

Gross Profit (p.s.)

6.709

Sales Per Share

EBITDA (p.s.)

2.521

Qtrly Earnings Growth

Operating Cash Flow (M)

5570.00

Levered Free Cash Flow (M)

3890.00

atoplab.com

Valuation

P/E

23.89

P/E Growth Ratio

P/BV

18.45

P/S

6933291520.00

P/CF

19.63

Dividend Yield

0.03

Dividends & Splits

Dividend

1.828

Dividend Pay Date

2018-05-15

Ex-Dividend Date

2018-04-12

Forward Dividend

1.120

Last Split Date

2013-01-02

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.